(HealthDay News) A new blood thinner called dabigatran etexilate may be just as effective in preventing dangerous venous clots as an old standby, warfarin, but much easier for doctors and patients to manage, a new study finds.
Dabigatran is marketed as Pradax in Canada and Pradaxa in Europe; it is not yet approved for use in the United States.
The new study, published early online Dec. 6 by the New England Journal of Medicine, follows on the heels of two other promising reports presented at the American Heart Association meeting in Orlando, Fla., last month. Those studies found that dabigatran appeared safe and effective in preventing blood clots when patients were treated for acute coronary syndrome, a cluster of symptoms that might indicate a heart attack; it was also found superior to warfarin in preventing strokes in patients with the irregular heartbeat known as atrial fibrillation. Read more...
Ayurtox for Body Detoxification
Ayurveda Asia Co. Ltd.- Our Company which managed the Integrated Medical Clinic and Ayurveda School as a unique healthcare facility, combining the strengths and knowledge of both traditional western and alternative medicine in a holistic manner.
Subscribe to:
Post Comments (Atom)
Health Begins In The Colon$19.99 The REAL Secret to Health is Finally Revealed! Did you know that disease starts and health begins in the colon? You can read more about how to better your health in Dr. Group's exclusive book |
No comments:
Post a Comment